The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase II/III study of perioperative nivolumab and ipilimumab in patients (pts) with locoregional esophageal (E) and gastroesophageal junction (GEJ) adenocarcinoma: A trial of the ECOG-ACRIN Cancer Research Group (EA2174).
 
Jennifer Rachel Eads
Employment - Bristol-Myers Squibb (I)
Honoraria - Pfizer
Consulting or Advisory Role - lexicon; Novartis
Research Funding - AstraZeneca (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Calithera Biosciences (Inst); EMD Serono (Inst); HealthCare Pharmaceuticals (Inst); Leap Therapeutics (Inst); MedImmune (Inst); Merck (Inst); Symphony Evolution (Inst); Tarveda Therapeutics (Inst); Verastem (Inst); Xencor (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb (I)
 
Michelle Weitz
No Relationships to Disclose
 
Michael K. Gibson
Speakers' Bureau - Bristol-Myers Squibb
 
Lakshmi Rajdev
Patents, Royalties, Other Intellectual Property - Bristol Myers Squibb, Boston Biomedical (Inst)
 
Onkar V Khullar
No Relationships to Disclose
 
Steven H. Lin
Honoraria - AstraZeneca/MedImmune
Speakers' Bureau - Varian Medical Systems
Research Funding - Genentech/Roche; Hitachi Chemical; New River Labs; STCube Pharmaceuticals Inc.
 
Constantine Gatsonis
Consulting or Advisory Role - Cyclopharma
Travel, Accommodations, Expenses - Medymatch
 
Ignacio Ivan Wistuba
Consulting or Advisory Role - AstraZeneca/MedImmune; Asuragen; Bayer; Bristol-Myers Squibb; Genentech/Roche; GlaxoSmithKline; Guardant Health; HTG Molecular Diagnostics; Merck; MSD Oncology; OncoCyte; Pfizer
Speakers' Bureau - MSD Oncology; Pfizer; Roche
Research Funding - 4D Molecular Therapeutics (Inst); Adaptimmune (Inst); Adaptive Biotechnologies (Inst); Akoya Biosciences (Inst); Amgen (Inst); Bayer (Inst); EMD Serono (Inst); Genentech (Inst); Guardant Health (Inst); HTG Molecular Diagnostics (Inst); Iovance Biotherapeutics (Inst); Johnson & Johnson (Inst); Karus Therapeutics (Inst); MedImmune (Inst); Merck (Inst); Novartis (Inst); OncoPlex Diagnostics (Inst); Pfizer (Inst); Silicon Biosytems (Inst); Takeda (Inst)
Travel, Accommodations, Expenses - AstraZeneca/MedImmune; Bristol-Myers Squibb; Genentech/Roche; GlaxoSmithKline; GlaxoSmithKline; Guardant Health; HTG Molecular Diagnostics; MSD Oncology; Pfizer
 
Aravind Sanjeevaiah
Travel, Accommodations, Expenses - NanoCarrier
 
Al Bowen Benson
Consulting or Advisory Role - Astellas Pharma; AXIO Research; Bayer; Bristol-Myers Squibb; Exelixis; Genentech/Roche; Guardant Health; inVentiv Health; Lilly; LSK BioPharma; Merck; NCCN; Purdue Pharma; Rafael Pharmaceuticals; Terumo; TheraBionic
Research Funding - Acerta Pharma; advanced accelerator applications (Inst); Bristol-Myers Squibb; Celgene; Infinity Pharmaceuticals (Inst); MedImmune; Merck Sharp & Dohme (Inst); Novartis (Inst); Taiho Pharmaceutical (Inst); Xencor
Travel, Accommodations, Expenses - Astellas Pharma; AVEO; Bayer; Boehringer Ingelheim; Boston Biomedical; Bristol-Myers Squibb; Dava Oncology; Genentech/Roche; Gilead Sciences; Guardant Health; guerbet; Helsinn Healthcare; Lilly/ImClone; Sanofi; Spectrum Pharmaceuticals; TRM Oncology
 
Nathan Bahary
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Celgene; Exelixis; Thermo Fisher Scientific
 
Kristen Renee Spencer
No Relationships to Disclose
 
Nabil F. Saba
Honoraria - Aduro Biotech; Bristol-Myers Squibb; CUE Biopharma; Genentech/Roche; GlaxoSmithKline; Kura Oncology; Lilly; Merck; Pfizer
Consulting or Advisory Role - Bristol-Myers Squibb; Lilly; Merck; Pfizer
Research Funding - Bristol-Myers Squibb; Exelixis
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Genentech/Roche; GlaxoSmithKline; Lilly; Merck; Pfizer
 
Stanley R. Hamilton
Stock and Other Ownership Interests - Johns Hopkins University School of Medicine
Consulting or Advisory Role - Bristol-Myers Squibb; Cell Medica/Kuur Therapeutics; Guardant Health; HalioDx; Loxo; Merck; Thermo Fisher Scientific
 
Charles A. Staley
No Relationships to Disclose
 
Anuradha Bapsi Chakravarthy
Research Funding - Novartis (Inst); Xoft (Inst)
 
Terence Z. Wong
Honoraria - Wake Radiology
Consulting or Advisory Role - Lucerno Dynamics
 
Peter J. O'Dwyer
Consulting or Advisory Role - Array BioPharma; Genentech
Research Funding - Amgen; Array BioPharma (Inst); Bayer; BBI Healthcare; Bristol-Myers Squibb; Celgene; Five Prime Therapeutics; Forty Seven; Genentech; GlaxoSmithKline; H3 Biomedicine (Inst); Lilly/ImClone (Inst); Merck; Mirati Therapeutics; Novartis; Pfizer; Pharmacyclics; Taiho Pharmaceutical (Inst)
Expert Testimony - Bayer; Lilly